Caeli Nova

Caeli Nova is a privately held aerospace and medical technology company based in London, England, founded in 2018.

The company focuses on developing advanced safety systems for the aviation industry, utilizing patented breathing technology to enhance oxygenation at high altitudes. Their mission is to address complex human-centered challenges in aviation and healthcare through innovative engineering. The flagship product, Cordillera, is a modernized emergency oxygen system designed for commercial and military aircraft. It protects passengers during cabin decompression events while minimizing operational constraints for airlines. Cordillera has received recognition, including a Crystal Cabin Award, for its ability to improve traditional emergency oxygen systems. The system enables airlines to operate more direct routes, reduces flight times and fuel consumption, and lowers carbon emissions, contributing to significant cost savings. Caeli Nova targets commercial airlines, military aircraft operators, and aircraft manufacturers, and has established strategic partnerships, including one with Airbus. The company is also exploring future applications of its oxygenation solutions in the medical sector and other industries.